- World No 2 deemed her level of fault ‘at the lowest end’
- Pole’s medication for jet lag and sleep was contaminated
Five-time grand slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine, a heart medication known as TMZ, the International Tennis Integrity Agency announced on Thursday.
Swiatek failed an out-of-competition drug test in August, and the ITIA accepted her explanation that the result was unintentional and was caused by the contamination of a nonprescription medication, melatonin, that Swiatek was taking for issues with jet lag and sleeping. It was determined her level of fault was “at the lowest end of the range for no significant fault or negligence”, the IATA said.